Evonik acquires silica business for 630 million US dollars
“The silica business has been part of Huber since the 1950s and paved the way for our company’s global expansion into engineered materials,” said Mike Marberry, President and Chief Executive Officer of Huber. “While it is difficult to part with a longstanding business, we see Evonik as an excellent strategic fit for both our silica customers and employees.”
The silica market is characterized by its variety of applications and shows above-average annual growth of 4 to 6 percent. Huber’s business is especially oriented towards applications in the consumer goods industry, the dental sector for example. To date, Evonik’s silica business has been focused rather on industrial applications, for example in the tire and coatings industries. “Combining the complementary silica businesses of Evonik and Huber will strengthen an important pillar of our portfolio,” explained Christian Kullmann, Executive Board Member for Strategy at Evonik. “Also, Huber Silica is an excellent regional fit with its focus on the U.S., China and India.”
For the 2016 financial year, Huber Silica is expected to achieve sales of close to 300 million US dollars and an EBITDA of 60 million US dollars. This corresponds to an attractive EBITDA margin of more than 20 percent.
Through the complementarity of the two business areas, Evonik expects to generate synergies of 20 million US dollars, largely in the areas of production, logistics and procurement as well as through harmonization of the product portfolio. Evonik expects to have all synergy measures implemented by 2021.
The depreciations customarily associated with asset deals will lead to lower future cash tax payments with a net present value of around 80 million US dollars. On this basis, the purchase price (enterprise value) including synergies and tax effects is about seven times the annual EBITDA, or 10.5 times before tax effects and synergies.
The transaction is scheduled to be completed in the second half of 2017, subject to approval by the responsible authorities. The acquisition is likely to have a positive impact on Evonik’s adjusted earnings per share as early as the first full financial year. Financing has been secured through Evonik’s own funds and committed credit facilities.
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.